Therefore, we analysed the efficiency of PI3K inhibition by applying the dual PI3K/mTOR inhibitor BEZ235 on pre‐B ALL cells together with MKC‐8866 and observed a striking increase in the fraction of apoptotic pre‐B ALL cells (Figures 3D and S3B,D). This evidence concerns the gene MTOR and acute lymphoblastic leukemia.